| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | -90.6% |
| R&D Expense | $284.8M | -11.2% |
| SG&A Expense | $73.5M | +0.8% |
| Operating Income | -$664.6M | -42.4% |
| Pre-tax Income | -$578.0M | -59.4% |
| Income Tax | $3.6M | +1.3% |
| Net Income | -$581.6M | -58.8% |
| EPS (Basic) | -$6.47 | -49.1% |
| EPS (Diluted) | -$6.47 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $347.6M | +16.5% |
| Short-term Investments | $1.63B | +1.4% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $1.99B | +2.5% |
| Total Assets | $2.27B | +1.0% |
| Current Liabilities | $149.1M | +69.9% |
| Total Liabilities | $343.4M | +10.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$345.0M | -141.7% |
| Capital Expenditures | $914K | -51.9% |
| Investing Cash Flow | -$31.8M | +88.7% |
| Financing Cash Flow | $426.0M | +28.3% |
| Free Cash Flow | -$345.9M | -139.1% |
| -49.1% |
| Stockholders' Equity |
| $1.92B |
| -0.5% |